Sign in to confirm you’re not a bot
This helps protect our community. Learn more

IRLAB Therapeutics | Q3 presentation by CEO, CFO and SVP R&D followed by a Q&A

Direkt Studios
46.2K subscribers
<__slot-el>
<__slot-el>
5.6K views Streamed 5 months ago
CEO Kristina Torfgård, CFO Viktor Siewertz and SVP R&D Nicholas Waters will be presenting. A Q&A will be following with participating Equity Analysts. 00:00 Intro 00:36 CEO Kristina Torfgård 02:16 Q3 Presentation - News and events in the period 08:32 EVP R&D Nicholas Waters - R&D Update 26:04 CEO Viktor Siewertz - Financial Highlights 29:40 CEO - Q3 summary 35:01 Q&A - Fredrik Thor, analyst Redeye 40:44 Q&A - Alexander Krämer, analyst ABG Sundal Collier 44:16 Q&A Arron Aatkar, analyst Edison Group ...more
...more
IRLAB Therapeutics | Q3 presentation by CEO, CFO and SVP R&D followed by a Q&A
CEO Kristina Torfgård, CFO Viktor Siewertz and SVP R&D Nicholas Waters will be presenting. A Q&A will be following with participating Equity Analysts. 00:00 Intro 00:36 CEO Kristina Torfgård 02:16 Q3 Presentation - News and events in the period 08:32 EVP R&D Nicholas Waters - R&D Update 26:04 CEO Viktor Siewertz - Financial Highlights 29:40 CEO - Q3 summary 35:01 Q&A - Fredrik Thor, analyst Redeye 40:44 Q&A - Alexander Krämer, analyst ABG Sundal Collier 44:16 Q&A Arron Aatkar, analyst Edison Group

Follow along using the transcript.

Direkt Studios

46.2K subscribers